Imexpharm Corp. (IMP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ben Tre Pharmaceutical JSC

DHG Pharmaceutical JSC

F.I.T. Investment JSC

Domesco Medical Import-Export JSC

Binh Dinh Pharmaceutical & Medical Equipment JSC

OPC Pharmaceutical JSC

Mediplantex National Pharmaceutical JSC

Imexpharm Corp.

Ha Tay Pharmaceutical JSC

Cuu Long Pharmaceutical JSC

Mekophar Chemical Pharmaceutical JSC

Why is Imexpharm Corp. ?

INTEREST(Q) At VND 6,177.51 MM has Grown at 180.04%
INTEREST COVERAGE RATIO(Q) Lowest at 2,306.28
DEBT-EQUITY RATIO (HY) Highest at -6.57 %

With ROE of 15.52%, it has a fair valuation with a 3.67 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 1.25%, its profits have risen by 31.7%

Underperformed the market in the last 1 year

The stock has generated a return of 1.25% in the last 1 year, much lower than market (Vietnam VN Ho Chi Minh Index) returns of 33.89%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Imexpharm Corp. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Imexpharm Corp.

-1.82%

1.72

31.06%

Vietnam VN Ho Chi Minh Index

29.95%

1.61

21.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.89%

EBIT Growth (5y)

14.65%

EBIT to Interest (avg)

28.50

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.03

Sales to Capital Employed (avg)

0.94

Tax Ratio

20.94%

Dividend Payout Ratio

25.88%

Pledged Shares

Institutional Holding

ROCE (avg)

20.58%

ROE (avg)

13.53%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.67

EV to EBIT

16.53

EV to EBITDA

13.47

EV to Capital Employed

3.86

EV to Sales

3.16

PEG Ratio

Dividend Yield

0.99%

ROCE (Latest)

23.35%

ROE (Latest)

15.52%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING CASH FLOW(Y)

Highest at VND 122,355.38 MM

ROCE(HY)

Highest at 15.69%

RAW MATERIAL COST(Y)

Fallen by -3.53% (YoY

NET PROFIT(9M)

Higher at VND 262,300.5 MM

CASH AND EQV(HY)

Highest at VND 999,377.21 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.13%

-13What is not working for the Company

INTEREST(Q)

At VND 6,177.51 MM has Grown at 180.04%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,306.28

DEBT-EQUITY RATIO (HY)

Highest at -6.57 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 6.24%

Here's what is working for Imexpharm Corp.

Net Profit

At VND 262,300.5 MM has Grown at 37.4%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (VND MM)

Operating Cash Flow

Highest at VND 122,355.38 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Cash and Eqv

Highest at VND 999,377.21 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 2.13%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Profit

Higher at VND 262,300.5 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (VND MM)

Raw Material Cost

Fallen by -3.53% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Imexpharm Corp.

Interest

At VND 6,177.51 MM has Grown at 180.04%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Interest Coverage Ratio

Lowest at 2,306.28

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at -6.57 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 6.24%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio